A significant legal action has been taken against a California-based digital health company and a Florida medical practice, both accused of participating in an alleged $100 million illegal Adderall distribution scheme. The federal grand jury indictment highlights the severity of the charges against the telehealth firm, particularly following the recent conviction of its CEO. The Justice Department is pursuing claims that this network, which includes Done Global Inc. and the Florida clinic, operated outside legal boundaries in distributing the medication. This situation has sent shockwaves through the San Francisco tech community as the implications of the indictments are being assessed.